TIL therapy for advanced lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This phase 1 study tests a new type of immunotherapy called TIL therapy, where your own immune cells are taken from a tumor, multiplied in a lab, and given back to fight the cancer. It is for people with advanced or recurrent non-small cell lung cancer who have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old
- You must have advanced or recurrent non-small cell lung cancer that has not been treated with certain therapies recently
- You must have at least one tumor that can be biopsied (at least the size of a small pea) to collect immune cells for the treatment
- Your overall health should be good enough to do most daily activities on your own (ECOG score 0 or 1)
- Your heart, lungs, liver, kidneys, and blood counts must be within certain safe limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a T-cell–based immunotherapy for people with metastatic non-small cell lung cancer that has grown despite prior treatment. It may help your immune system recognize and fight your cancer using cells made from your tumor.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This trial tests a treatment using your own immune cells (TILs) to fight advanced solid tumors. If you have a tumor that can be removed to make the TILs, and you've tried other treatments without success, you may be eligible.
This trial tests a personalized therapy using your own immune cells (TILs) combined with immunotherapy to fight advanced breast cancer that has not responded to other treatments. It may help if you have a tumor that can be biopsied and you are generally healthy enough for the procedures.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This trial tests a new type of personalized cell therapy (TIL) for people with advanced solid tumors who have run out of standard treatment options. It aims to see if this approach can help shrink tumors.
Hear when a new Advanced Non-Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.